Atlas Trials

Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer

Clinical trial NCT02497157 · COMPLETED

Trial details

NCT number
NCT02497157
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2015-05-21
Primary completion
2019-06-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.